Literature DB >> 33330962

Extracellular Vesicle Therapeutics in Regenerative Medicine.

Aya Imafuku1, Sebastian Sjoqvist2,3.   

Abstract

Extracellular vesicles (EVs) are nano-sized, cell-released vesicles which contain lipids, proteins, and nucleic acids derived from the parental cells. EVs play an important role in intercellular communication and influence both physiological and pathological conditions. They are increasingly explored as potential therapeutic agents since they can cross biological barriers, their cargo is protected from degradation and they are involved in the transfer of bioactive components. EVs can promote tissue regeneration and might be alternatives to cell therapy. They can be used both in their native form, and as delivery vehicles for therapeutic agents. However, there are many hurdles to overcome for broad clinical application of EVs as therapeutics. Here, we review recent conditions regarding EVs therapeutics in regenerative medicine.
© 2020. Springer Nature Switzerland AG.

Entities:  

Keywords:  Extracellular vesicle; Graft versus host disease; Induced pluripotent stem cell; Inflammatory diseases; Mesenchymal stromal cell

Year:  2021        PMID: 33330962     DOI: 10.1007/5584_2020_599

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  25 in total

Review 1.  Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities.

Authors:  Jacques Galipeau; Luc Sensébé
Journal:  Cell Stem Cell       Date:  2018-06-01       Impact factor: 24.633

2.  Oral administration of bovine milk derived extracellular vesicles attenuates arthritis in two mouse models.

Authors:  Onno J Arntz; Bartijn C H Pieters; Marina C Oliveira; Mathijs G A Broeren; Miranda B Bennink; Marieke de Vries; Peter L E M van Lent; Marije I Koenders; Wim B van den Berg; Peter M van der Kraan; Fons A J van de Loo
Journal:  Mol Nutr Food Res       Date:  2015-07-01       Impact factor: 5.914

Review 3.  Mesenchymal stem cells from different sources and their derived exosomes: A pre-clinical perspective.

Authors:  María Álvarez-Viejo
Journal:  World J Stem Cells       Date:  2020-02-26       Impact factor: 5.326

4.  Therapeutic efficacy of cardiosphere-derived cells in a transgenic mouse model of non-ischaemic dilated cardiomyopathy.

Authors:  Mohammad A Aminzadeh; Eleni Tseliou; Baiming Sun; Ke Cheng; Konstantinos Malliaras; Raj R Makkar; Eduardo Marbán
Journal:  Eur Heart J       Date:  2014-05-27       Impact factor: 29.983

5.  Intranasal Delivery of Mesenchymal Stem Cell Derived Exosomes Loaded with Phosphatase and Tensin Homolog siRNA Repairs Complete Spinal Cord Injury.

Authors:  Shaowei Guo; Nisim Perets; Oshra Betzer; Shahar Ben-Shaul; Anton Sheinin; Izhak Michaelevski; Rachela Popovtzer; Daniel Offen; Shulamit Levenberg
Journal:  ACS Nano       Date:  2019-08-29       Impact factor: 15.881

6.  Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection.

Authors:  Ivan Gutierrez-Aranda; Veronica Ramos-Mejia; Clara Bueno; Martin Munoz-Lopez; Pedro J Real; Angela Mácia; Laura Sanchez; Gertrudis Ligero; Jose L Garcia-Parez; Pablo Menendez
Journal:  Stem Cells       Date:  2010-09       Impact factor: 6.277

7.  Grape exosome-like nanoparticles induce intestinal stem cells and protect mice from DSS-induced colitis.

Authors:  Songwen Ju; Jingyao Mu; Terje Dokland; Xiaoying Zhuang; Qilong Wang; Hong Jiang; Xiaoyu Xiang; Zhong-Bin Deng; Baomei Wang; Lifeng Zhang; Mary Roth; Ruth Welti; James Mobley; Yan Jun; Donald Miller; Huang-Ge Zhang
Journal:  Mol Ther       Date:  2013-06-11       Impact factor: 11.454

8.  Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs.

Authors:  Eduard Hergenreider; Susanne Heydt; Karine Tréguer; Thomas Boettger; Anton J G Horrevoets; Andreas M Zeiher; Margot P Scheffer; Achilleas S Frangakis; Xiaoke Yin; Manuel Mayr; Thomas Braun; Carmen Urbich; Reinier A Boon; Stefanie Dimmeler
Journal:  Nat Cell Biol       Date:  2012-02-12       Impact factor: 28.824

9.  Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs.

Authors:  Tian Sheng Chen; Fatih Arslan; Yijun Yin; Soon Sim Tan; Ruenn Chai Lai; Andre Boon Hwa Choo; Jayanthi Padmanabhan; Chuen Neng Lee; Dominique P V de Kleijn; Sai Kiang Lim
Journal:  J Transl Med       Date:  2011-04-25       Impact factor: 5.531

10.  miRNA in plasma exosome is stable under different storage conditions.

Authors:  Qinyu Ge; Youxia Zhou; Jiafeng Lu; Yunfei Bai; Xueying Xie; Zuhong Lu
Journal:  Molecules       Date:  2014-01-27       Impact factor: 4.411

View more
  3 in total

1.  An Overview of Current Research on Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Bibliometric Analysis From 2009 to 2021.

Authors:  Xudong Zhang; Yimeng Lu; Shanshan Wu; Siwen Zhang; Shuyu Li; Jichun Tan
Journal:  Front Bioeng Biotechnol       Date:  2022-06-24

Review 2.  Extracellular Vesicles Released from Stem Cells as a New Therapeutic Strategy for Primary and Secondary Glomerulonephritis.

Authors:  Marco Quaglia; Guido Merlotti; Laura Fornara; Andrea Colombatto; Vincenzo Cantaluppi
Journal:  Int J Mol Sci       Date:  2022-05-20       Impact factor: 6.208

Review 3.  Exosomes: Small Vesicles with Important Roles in the Development, Metastasis and Treatment of Breast Cancer.

Authors:  Ling'ao Meng; Kedong Song; Shenglong Li; Yue Kang
Journal:  Membranes (Basel)       Date:  2022-08-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.